Resultados de la búsqueda 71-80 of 9527 for B cell lymphomas

  1. Hematología - Ensayos clínicos

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

  2. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  6. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  7. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  8. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  9. Hematología - Ensayos clínicos

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

  10. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...